PharmaShots Weekly Snapshot (January 14 -18, 2019)

  1. Knight Therapeutics Signs an Exclusive License Agreement with Puma Biotechnology for its Nerlynx (neratinib)

Published: 14 Jan, 2019 | Tags: Knight Therapeutics, Signs, Exclusive, License, Agreement, Puma Biotechnology, Nerlynx, (neratinib), $7.2M, HER2-overexpressed/amplified BC

  1. Chiesi Farmaceutici Licenses Tum Bio’s NCE401 for $74M

Published: 14 Jan, 2019 | Tags: Chiesi FDiseasesarmaceutici, Licenses, Tum Bio, NCE401, $74M, Fibrotic

  1. Ascletis Signs an Exclusive License Agreement with Alphamab for its KN035

Published: 14 Jan, 2019 | Tags: Ascleti, Signs, Exclusive, License, Agreeement, Alphamab, KN035

  1. Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Receives EU Approval for 1L Intermediate- and Poor-Risk Advanced RCC

Published: 15 Jan, 2019 | Tags: Bristol-Myers Squibb, (BMS), Opdivo, (nivolumab), Low-Dose Yervoy, (ipilimumab), Receives, EU, Approval, 1L, Renal Cell Carcinoma, (RCC)

  1. Exelixis’ Cabometyx (cabozantinib) Receives FDA Approval for Previously Treated Hepatocellular Carcinoma (HCC)

Published:  15 Jan, 2019 | Tags: Exelixis, Cabometyx, (cabozantinib), Receives, FDA, Approval, Previously, Treated, Hepatocellular Carcinoma (HCC)

  1. Array Biopharma Reports Results of Triplet Combination Therapy in P-III BEACON CRC Trial for BRAF-Mutant Metastatic Colorectal Cancer (mCRC)

Published: 15 Jan, 2019 | Tags: Array Biopharma, Reports, Results, Triplet, Combination Therapy, P-III, BEACON CRC Trial, BRAF-Mutant Metastatic Colorectal Cancer, (mCRC), Braftovi, Mektovi, Erbitux

  1. Cipla Signs an Exclusive License Agreement with Bio-Thera for its BAT1706 (bevacizumab, biosimilar)

Published: 15 Jan, 2019 | Tags: Cipla, Signs, Exclusive, License, Agreement, Bio-Thera, BAT1706, bevacizumab, biosimilar, Avastin, Genetech, NSCLC

  1. Abbott’s Amplatzer Piccolo Occluder Receives FDA Approval, a Medical Device for Premature and Newborns with Patent Ductus Arteriosus (PDA)

Published: 15 Jan, 2019 | Tags: Abbott, Amplatzer Piccolo Occluder, Receives, FDA, Approval, Medical Device, Premature, Newborns, Patent Ductus Arteriosus, (PDA)

  1. Sanofi Licenses Biomunex Pharmaceuticals’ BiXAb Technology to Develop Bi- and Multi-Specific Antibodies

Published: 16 Jan, 2019 | Tags: Sanofi, Licenses, Biomunex Pharmaceuticals, BiXAb, Technology, Develop, Bi- Multi-Specific Antibodies

  1. Beigene’s Zanubrutinib (BGB-3111) Receives the US FDA’s Breakthrough Therapy Designation for Mantle Cell Lymphoma (MCL)

Published: 16 Jan, 2019 | Tags: Beigene, Zanubrutinib, (BGB-3111), Receives, the US FDA, Breakthrough Therapy Designation, Mantle Cell Lymphoma, (MCL)

  1. Boehringer Ingelheim (BI) and Bioharmony Therapeutics Collaborates to Develop Bacteriophage Lysins

Published: 16 Jan, 2019 | Tags: Boehringer Ingelheim, (BI), Bioharmony Therapeutics, Collaborates, Develop, Bacteriophage Lysins

 

  1. Ironwood Pharmaceuticals’ Linzess (linaclotide) Receives NMPA (CMPA) Approval for Irritable Bowel Syndrome with Constipation (IBS-C)

Published:16 Jan, 2019 | Tags: Ironwood Pharmaceuticals, Linzess, (linaclotide), Receives, NMPA, (CMPA), Approval, Irritable Bowel Syndrome, Constipation, (IBS-C)

  1. Abbott Exercises its Option to Acquire Cephea Valve Technologie

Published: 17 Jan, 2019 | Tags: Abbott, Exercises, Option, Acquire, Cephea Valve Technologies, heart-valve, replacement technology

  1. Roche Launches uPath Enterprise Software, a Digital PathologyTechnology

Published: 17 Jan, 2019 | Tags: Roche, Launches, uPath Enterprise Software, Digital, Pathology, Software

  1. AstraZeneca Signs an Exclusive Promotion Agreement with Luye Pharma for its Xuezhikang in China

Published:17 Jan, 2019 | Tags: AstraZeneca Signs an Exclusive Promotion Agreement with Luye Pharma for its Xuezhikang in China

  1. FitBit and National Institutes of Health (NIH) Launches a Digital Health Project, Fitbit Bring-Your-Own-Device (BYOD)

Published: 17 Jan, 2019 | Tags: FitBit, National Institutes of Health, (NIH), Launches, Digital, Health Project, Fitbit, Bring-Your-Own-Device, (BYOD)

  1. Johnson & Johnson (J&J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib)

Published: 18 Jan, 2019 | Tags: Johnson & Johnson, (J&J), Signs, Research, Collabortaion, Apple, AFib, (Atrial Fibrillation)

  1. BioMed X and Boehringer Ingelheim (BI) Collaborates for Neurology Disorders

Published: 18 Jan, 2019 | Tags: BioMedX, Boehringer Ingelheim, (BI), Collaborates, Neurology, Disorders, Psychiatric Disorders

  1. CorMedix Reports Results of Neutrolin in P-III LOCK-IT-100 Study for Patients with Hemodialysis

Published: 18 Jan, 2019 | Tags: CorMedix, Reports, Results, Neutrolin, P-III, LOCK-IT-100 Study, Patient, Hemodialysis

  1. Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies

Published: 18 Jan, 2019 | Tags: Thyas, Signs, Exclusive, Licenses, Agreeemnt, iPS Academia Japan, (iPS-AJ), Develop, Autologous, Immunotherapies

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post